Bio-Rad Laboratories Class A
261 hedge funds and large institutions have $3.6B invested in Bio-Rad Laboratories Class A in 2016 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 90 increasing their positions, 81 reducing their positions, and 27 closing their positions.
775% more call options, than puts
Call options by funds: $6.39M | Put options by funds: $730K
85% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 27
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
18% more capital invested
Capital invested by funds: $3.05B → $3.6B (+$548M)
11% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 81
8% more funds holding
Funds holding: 241 → 261 (+20)
2.2% more ownership
Funds ownership: 78.6% → 80.8% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
+$89M |
| 2 |
Morgan Stanley
New York
|
+$65.1M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$52.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.2M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$51.8M |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$38.4M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$33.2M |
| 4 |
LCS
Levin Capital Strategies
New York
|
-$18.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$12.6M |
BIO Hedge Fund Activity: Q4 2016 in Review
261 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2016, worth a combined $3.6B — up 18% from $3.05B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new BIO positions and 27 closed out — a net gain of 23 holders — while 90 added to existing stakes and 81 trimmed.
The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $89M. The largest seller was Credit Suisse, cutting an estimated $51.8M.
- 261 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2016, up from 241 in Q3 2016.
- Funds reported $3.6B of Bio-Rad Laboratories Class A stock for Q4 2016, up 18% quarter-over-quarter.
- 50 funds opened new Bio-Rad Laboratories Class A positions in Q4 2016 and 27 closed out, a net change of +23 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2016 was TimesSquare Capital Management, an estimated $89M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2016 was Credit Suisse, an estimated $51.8M sold.
Based on aggregated 13F filings for Q4 2016.